Try
COLLEGIUM PHARMACEUTICAL, INC
COLLUnited States
66 filed reports · 574 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
66 reports · Mar 2015 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 41 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 34 | 4,681 | Jun 2015 to Jun 2026 |
| Current · 8-KSEC EDGAR | 20 | 41 | Dec 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 11 | 4,756 | Dec 2015 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 62 | Mar 2015 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 445 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 255 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,017 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 26, 2026 | 2 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 265 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 166 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 165 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 8, 2025 | 2 | Open |
Financial data
574 concepts · 9,540 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial548 concepts · 9,012 facts · Dec 2013 to Jul 2026
- Cash and cash equivalents at carrying value64 · Dec 2013 to Jun 2026
- Increase decrease in accounts payable63 · Dec 2013 to Jun 2026
- Increase decrease in accrued liabilities63 · Dec 2013 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets63 · Dec 2013 to Jun 2026
- Net income loss63 · Dec 2013 to Jun 2026
- Operating income loss63 · Dec 2013 to Jun 2026
- Proceeds from stock options exercised63 · Dec 2013 to Jun 2026
- Share based compensation63 · Dec 2013 to Jun 2026
- Common stock shares issued61 · Dec 2013 to Jun 2026
- Common stock shares outstanding61 · Dec 2013 to Jun 2026
- Stockholders equity (US GAAP)61 · Dec 2013 to Jun 2026
- Common stock par or stated value per share60 · Dec 2013 to Jun 2026
- Common stock shares authorized60 · Dec 2013 to Jun 2026
- Accounts payable current59 · Dec 2014 to Jun 2026
- Accrued liabilities current59 · Dec 2014 to Jun 2026
- Accrued professional fees current59 · Dec 2014 to Jun 2026
- Additional paid in capital59 · Dec 2014 to Jun 2026
- Assets59 · Dec 2014 to Jun 2026
- Assets current59 · Dec 2014 to Jun 2026
- Common stock value59 · Dec 2014 to Jun 2026
- Employee related liabilities current59 · Dec 2014 to Jun 2026
- Interest payable current59 · Dec 2014 to Jun 2026
- Liabilities59 · Dec 2014 to Jun 2026
- Liabilities and stockholders equity59 · Dec 2014 to Jun 2026
Product10 concepts · 343 facts · Dec 2016 to Jun 2026
- Revenue231 · Dec 2016 to Jun 2026
- Cost of goods and services sold amortization50 · Dec 2023 to Jun 2026
- Amortization of intangible assets38 · Dec 2017 to Sep 2024
- Intangible asset amortization and impairment13 · Dec 2020 to Dec 2024
- Impairment of intangible assets finitelived3 · Dec 2022 to Dec 2023
- Nucynta Products2 · Mar 2020 to Jun 2020
- Total cost2 · Mar 2020 to Jun 2020
- Xtampza ER2 · Dec 2020 to Mar 2021
- BDSI1 · Dec 2016
- Severance costs11 · Dec 2022
Segment13 concepts · 143 facts · Dec 2022 to Jun 2026
- Allocated share based compensation expense14 · Dec 2022 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment reporting other item amount13 · Dec 2022 to Jun 2026
- Segment12 · Dec 2022 to Jun 2026
- Intangible asset amortization and impairment8 · Dec 2022 to Jun 2026
- Investment income net8 · Dec 2022 to Jun 2026
- Cost of goods and services sold amortization6 · Mar 2024 to Sep 2025
- Gains losses on extinguishment of debt6 · Dec 2023 to Dec 2025
- Investment income interest6 · Mar 2024 to Sep 2025
Guidance2 concepts · 41 facts · Feb 2022 to Aug 2026
- Revenue Guidance40 · Feb 2022 to Aug 2026
- Revenue Growth Guidance1 · Nov 2023
Geography1 concepts · 1 facts · Dec 2025
- Operating lease impairment loss1 · Dec 2025
Segments
487 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis17 members · 333 facts
- Nucynta54 · Mar 2018 to Jun 2026
- Belbuca47 · Mar 2022 to Jun 2026
- Xtampza42 · Dec 2016 to Sep 2025
- Symproic40 · Mar 2022 to Jun 2026
- Nucynta Er34 · Dec 2018 to Sep 2025
- Nucynta Ir34 · Dec 2018 to Sep 2025
- Jornay Pm24 · Dec 2023 to Jun 2026
- Elyxyb14 · Mar 2022 to Dec 2023
- Nucynta ER7 · Dec 2023 to Jun 2026
- Nucynta IR7 · Dec 2023 to Jun 2026
- Xtampza ER7 · Dec 2023 to Jun 2026
- Symproic And Other6 · Dec 2023 to Dec 2025
- Azstarys4 · Jun 2025 to Jun 2026
- Bema Fentany4 · Mar 2022 to Dec 2022
- Nucynta ERAG4 · Mar 2025 to Jun 2026
- Nucynta IRAG4 · Mar 2025 to Jun 2026
- Onsolis1 · Dec 2017
Statement business segments1 member · 143 facts
- Single Reportable143 · Dec 2022 to Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis3 members · 10 facts
- Xtampza6 · Mar 2017 to Sep 2018
- Nucynta3 · Mar 2018 to Sep 2018
- Onsolis1 · Dec 2016
Statement geographical1 member · 1 facts
- Durham North Carolina1 · Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.